Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma

Archives of Ophthalmology

Volumn 115, Issue 9, 1997, Pages 1157-1160

  Whitcup, Scott M ^a   Stark Vanes, Virginia ^a   Wittes, Robert E ^a   Solomon, Diane ^b   Podgor, Marvin J ^a   Nussenblatt, Robert B ^b   Chan, Chi Chao ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6;

ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ERROR; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE TUMOR; HUMAN; LYMPHOMA; PRIORITY JOURNAL; UVEITIS; VITREOUS BODY;

EID: 0030886490     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1997.01100160327010     Document Type: Article

References (24)

1. DeAngelis LM, Yahalom J, Thaler HT, Kher U. Combined modality therapy for primary CMS lymphoma. JClin Oncol. 1992;10:635-643.
2. Appen RE. Posterior uveitis and primary cerebral reticulum cell sarcoma. Arch Ophthalmol. 1975;93:123-124.
3. Rockwood EJ, Zakov ZN, Bay JW. Combined malignant lymphoma of the eye and CMS (reticulum cell sarcoma). JNeurosurg. 1984;61:369-374.
4. Hochberg FH, Miller DC. Primary central nervous system lymphoma. JNeurosurg. 1988:68:835-853.
5. Freeman LN, Schachat AP, Knox DL, et al. Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology. 1987; 94:1631-1639.
6. Whitcup SM, de Smet MD, Rubin Bl, et al. Intraocular lymphoma: clinical and histopathologic diagnosis. Ophthalmology. 1993;100:1399-1406.
7. Rousset F, Garcia E, Defrance T, et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA. 1992:89:1890-1893.
8. Fluckiger AC, Dlurand I, Banchereau J. Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. JExp Med. 1994;179:91-99.
9. Benjamin D, Kuobloch TJ, Dayton MA. Human interleukin 10: B cell lines derived from patients with AIDS and Burkitt's lymphoma constitutively secrete large quantities of interleukin 10. Blood. 1992:80:1289-1298.
10. Stewart JP, Behm FG, Arrand JR, Rooney CM. Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumor and B cell lines. Virology. 1994:200:724-732.
11. Blay JY, Burdin N, Rousset F, et al. Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood. 1993:82:2169-2174.
12. Chan CC, Whitcup SM, Solomon D, Nussenblatt RB. Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol. 1995; 120:671-673.
13. Hoekyma R, Murray PI, van Haren MAC, Helle M, Kijlstra A. Analysis of interleukin-6 in endotoxin-induced uveitis. Invest Ophthalmol Vis Sei. 1991 ;32:88-95.
14. Murray PI, Hoekyma R, van Haren MAC, de Hon FP, Kijlstra A. Aqueous humor interleukin-6 levels in uveitis. Invest Ophthalmol Vis Sei. 1990:31:917-920.
15. De Vos AF, Hoekzema R, Kijlstra A. Cytokines and uveitis: a review. CurrEye Res. 1992:11:581-597.
16. Davis JL, Solomon D, Nussenblatt RB, et al. Immunocytochemical staining of vitreous cells: indications, techniques, and results. Ophthalmology. 1992;99: 250-256.
17. Ljung BM, Char D, Miller TR, Deschenes J. Intraocular lymphoma cytologie diagnosis and the role of immunologie markers. Acta Cytol. 1988:32:840-847.
18. Donald A, Donner A. Adjustments to the Mantel-Haenszel chi-square statistic and odds ratio variance estimator when the data are clustered. Stat Med. 1987;6: 491-499.
19. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986:73:13-22.
20. Lipsitz SR, Harrington DP. Analyzing correlated binary data using SAS. Computers Biomed Res. 1990:23:268-282.
21. Nussenblatt RB, Palastine AG, Chan CC, et al. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985;92: 467-471.
22. Ross ME, Tan JC, Chou CC, et al. Lymphomagenesis in the SCID-hu mouse involves abundant production of human interleukin-10. Blood. 1995:85:1063-1074.
23. Matsuda M, Blankenstein T, Karre K, Kiessling R. IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expression. J Immunol. 1995:154:6291-6298.
24. Bost KL, Bieligk SC, Jaffe BM. Lymphokine mRNA expression by transplantable murine B lymphocytic malignancies: tumor-derived IL-10 as a possible mechanism for modulating the anti-tumor response. J Immunol. 1995:154:718-729.